Announcements Trials

Browse Landscape

Status

Unknown 2 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Small Cell Lung Carcinoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Heart Diseases 1 Colorectal Neoplasms 1 Cardiotoxicity 1

Interventions

Echocardiography 2 liposomal doxorubicin 1 Vitamin E 1 Vitamin D 1 Tomography, X-Ray Computed 1 Tomography, Emission-Computed 1 Surveys and Questionnaires 1 Progestins 1 Positron-Emission Tomography 1 Nutrition Assessment 1 Methods 1 Mass Screening 1 Magnetic Resonance Imaging 1 Interviews as Topic 1 Immunomodulating Agents 1 Immune Checkpoint Inhibitors 1 Hormone Replacement Therapy 1 Hematologic Tests 1 Exercise Test 1 Estrogens 1 Estrogen Replacement Therapy 1 Educational Status 1 Dietary Supplements 1 Diet, Fat-Restricted 1 Calcium 1 Breathing Exercises 1 Blood Specimen Collection 1 Aspirin 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Heart Diseases × Antineoplastic Agents × Clear all

NCT03530215 2023-04-13

EROCA

Groupe Hospitalier Pitie-Salpetriere

500,000 enrolled

Heart Diseases, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡